These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25560872)

  • 1. Development and implementation of a cohort review for latent TB infection.
    Mancuso JD; Aaron CL
    Chest; 2015 Jan; 147(1):e25-e26. PubMed ID: 25560872
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief report: number of tuberculosis tests and diagnoses of latent tuberculosis infection in active component service members, U.S. Armed Forces, January 2004-December 2014.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2014 Dec; 21(12):8-10; discussion 9-10. PubMed ID: 25555209
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges in diagnosis and treatment of latent tuberculosis infection.
    Gupta KB
    Indian J Tuberc; 2012 Jan; 59(1):1-5. PubMed ID: 22670504
    [No Abstract]   [Full Text] [Related]  

  • 5. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study.
    Snast I; Bercovici E; Avni T; Shitenberg D; Hodak E; Pavlovsky L
    Acta Derm Venereol; 2018 Nov; 98(10):979-980. PubMed ID: 30085327
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and the military.
    O'Shea MK; Wilson D
    J R Army Med Corps; 2013 Sep; 159(3):190-9. PubMed ID: 24109141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.
    Campbell JR; Dowdy D; Schwartzman K
    PLoS Med; 2019 Jun; 16(6):e1002824. PubMed ID: 31170161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active tuberculosis and recent overseas deployment in the U.S. Military.
    Nevin RL
    Am J Prev Med; 2010 Dec; 39(6):e39-40; author reply e40. PubMed ID: 21084066
    [No Abstract]   [Full Text] [Related]  

  • 11. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries?
    Abud-Mendoza C; Martínez-Martínez MU; DE Jesús Macías-Mendoza J; Magaña-Aquino M
    J Rheumatol; 2010 Mar; 37(3):672-3; author reply 673. PubMed ID: 20197567
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From latent to patent: rethinking prediction of tuberculosis.
    Cobelens F; Kik S; Esmail H; Cirillo DM; Lienhardt C; Matteelli A
    Lancet Respir Med; 2017 Apr; 5(4):243-244. PubMed ID: 28017341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Latent tuberculosis].
    Bonomo C; Brändli O; Rampini SK
    Praxis (Bern 1994); 2011 Feb; 100(3):125-36. PubMed ID: 21290367
    [No Abstract]   [Full Text] [Related]  

  • 15. Focus on latent tuberculosis.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Oct; 4(10):763. PubMed ID: 27707455
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI.
    Martínez-Pino I; Sambeat MA; Lacalle-Remigio JR; Domingo P;
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1545-51. PubMed ID: 24200266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent infection treatment to prevent TB transmission in school settings.
    Lee PH; Chang FY
    J Formos Med Assoc; 2012 Oct; 111(10):525-6. PubMed ID: 23089686
    [No Abstract]   [Full Text] [Related]  

  • 19. Think Globally, Act Locally: Diagnosis and Management of Latent Tuberculosis in Minnesota's Foreign-Born Population.
    Goers M; Settgast A
    Minn Med; 2015 Sep; 98(9):49-52. PubMed ID: 26442358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas.
    Khawcharoenporn T; Apisarnthanarak A; Sungkanuparph S; Woeltje KF; Fraser VJ
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):14-23. PubMed ID: 21276291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.